West E, Zeeb M, Grube C, Kuster H, et al. Sustained viral suppression with dolutegravir monotherapy over 192 weeks in patients starting combination antiretroviral therapy during primary HIV infection (EARLY-SIMPLIFIED): a randomized, controlled, multi-site, non-inferiority trial. Clin Infect Dis 2023 Jun 20:ciad366. doi: 10.1093.
PMID: 37338148